{"id":11578,"date":"2025-05-02T19:54:48","date_gmt":"2025-05-02T19:54:48","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/cphi-south-east-asia-2025-your-gateway-to-aseans-expanding-pharmaceutical-landscape\/"},"modified":"2025-05-02T19:54:48","modified_gmt":"2025-05-02T19:54:48","slug":"cphi-south-east-asia-2025-your-gateway-to-aseans-expanding-pharmaceutical-landscape-2","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=11578","title":{"rendered":"CPHI South East Asia 2025: Your gateway to ASEAN’s expanding pharmaceutical landscape"},"content":{"rendered":"

KUALA LUMPUR, Malaysia<\/span><\/span>, May 2, 2025<\/span><\/span> \/PRNewswire\/ — As Southeast Asia’s<\/span> pharmaceutical industry rapidly evolves\u2014driven by regulatory harmonization, innovation, and growing healthcare demand\u2014CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and unlock business opportunities across the ASEAN region.<\/p>\n

\n

\"CPHI <\/a>
CPHI South East Asia 2025 will be held from 16-18 July 2025 at MITEC, Kuala Lumpur, Malaysia<\/span><\/p>\n<\/div>\n

Taking place for the first time in Kuala Lumpur, Malaysia<\/span>, from 16\u201318 July 2025, the event will bring together 8,000+ professionals, 400+ global exhibitors, and curated buyers from across Asia<\/span> and beyond\u2014positioning it as the region’s most impactful pharma event.<\/p>\n

Unlock Growth Across ASEAN’s Pharma Markets<\/b><\/p>\n

From Indonesia<\/span>, Thailand<\/span>, Vietnam<\/span>, the Philippines<\/span> to Malaysia<\/span>, Southeast Asia<\/span> is one of the world’s most dynamic pharmaceutical regions. Governments are investing in local manufacturing, reforming regulatory systems, and opening doors to international partnerships.<\/p>\n

Malaysia<\/span>, as this year’s host, plays a central role in this growth. [1]<\/span><\/sup>The country’s pharmaceutical market is expected to rise from RM11.2 billion<\/span> in 2022 to RM15.5 billion<\/span> by 2027, supported by the New Industrial Master Plan (NIMP) 2030, which incentivizes the production of APIs, biologics, and vaccines.<\/p>\n

[2]<\/span><\/sup>Strategically located between Singapore<\/span> and Indonesia<\/span>, Malaysia<\/span> offers streamlined access to regional distributors, CDMOs, and packaging partners\u2014making Kuala Lumpur<\/span> a strategic gateway to ASEAN-wide expansion.<\/p>\n

\n\n\n\n\n
\n

Source: 1. MIDA, MITI Malaysia<\/u><\/i><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

2. ASEAN Pharmaceutical Industry Report<\/u><\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

At CPHI South East Asia 2025, you’ll be able to:<\/b><\/p>\n